A patent review of pharmaceutical and therapeutic applications of oxadiazole derivatives for the treatment of chronic diseases (2013-2021)
- PMID: 35993146
- DOI: 10.1080/13543776.2022.2116312
A patent review of pharmaceutical and therapeutic applications of oxadiazole derivatives for the treatment of chronic diseases (2013-2021)
Abstract
Introduction: Oxadiazole is a unique class of heterocycle, possessing numerous important biomedical and therapeutic applications, such as anti-bacterial, anti-cancer, anti-inflammatory, inhibitors for diverse enzymes, receptor modulators, and neuroprotective properties. The rapid development in the field of oxadiazole-containing structures is confirmed by the development of numerous clinical drugs, such as doxazosin, nesapidil, pleconaril, fasiplon, ataluren, zibotentan, and prenoxdiazine as selected examples.
Areas covered: This review provides a comprehensive overview of the range of biological applications of oxadiazole-containing drugs in a range of patents from 2013 to 2021. The information was collected from available data sources including SciFinder, Reaxys, MedLine, and Chemical Abstracts.
Expert opinion: Oxadiazole is an established class of compounds with fascinating biological properties. The importance of oxadiazoles can be recognized by their enormous application in a wide spectrum of medicinal chemistry from anticancer, lantibiotics, and antidiabetics to their use in agriculture and neuroprotection. For instance, the oxadiazole-based compounds have shown the ability to modulate a variety of receptors including the M4 receptor agonists, S1P1 receptor modulators, SSTR5 antagonists, orexin type-2 receptor agonists, liver X receptor agonists, and many more. This testifies to the special features associated with the oxadiazole scaffold, making it a significant pharmacophore.
Keywords: Oxadiazole; S1PR; antibiotic; anticancer; antifungal; drug development; receptor modulators.
Similar articles
-
Substituted oxadiazoles: a patent review (2010 - 2012).Expert Opin Ther Pat. 2013 Sep;23(9):1209-32. doi: 10.1517/13543776.2013.797409. Epub 2013 May 10. Expert Opin Ther Pat. 2013. PMID: 23663160 Review.
-
Recent Advancement in Synthesis and Bioactivities of 1,3,4-Oxadiazole.Curr Org Synth. 2023;20(6):663-677. doi: 10.2174/1570179420666221129153933. Curr Org Synth. 2023. PMID: 36453511
-
A Review of the Biological Activities of Heterocyclic Compounds Comprising Oxadiazole Moieties.Curr Top Med Chem. 2022;22(7):578-599. doi: 10.2174/1568026622666220202123651. Curr Top Med Chem. 2022. PMID: 35114924 Review.
-
1,2,4-Oxadiazole as a Privileged Scaffold for Anti-inflammatory and Analgesic Activities: A Review.Mini Rev Med Chem. 2018;18(18):1536-1547. doi: 10.2174/1389557518666180524112050. Mini Rev Med Chem. 2018. PMID: 29792145 Review.
-
A Review Exploring Therapeutic Worth of 1,3,4-Oxadiazole Tailored Compounds.Mini Rev Med Chem. 2019;19(6):477-509. doi: 10.2174/1389557518666181015152433. Mini Rev Med Chem. 2019. PMID: 30324877 Review.
Cited by
-
Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles.Int J Mol Sci. 2023 Mar 12;24(6):5406. doi: 10.3390/ijms24065406. Int J Mol Sci. 2023. PMID: 36982481 Free PMC article. Review.
-
Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells.Molecules. 2023 Jul 26;28(15):5658. doi: 10.3390/molecules28155658. Molecules. 2023. PMID: 37570631 Free PMC article.
-
Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.Int J Mol Sci. 2022 Dec 12;23(24):15768. doi: 10.3390/ijms232415768. Int J Mol Sci. 2022. PMID: 36555409 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources